Boston's Clik Anchor spinal lead fixation device approved in the US
This article was originally published in Clinica
Executive Summary
The Clik Anchor, a device developed by Boston Scientific to aid placement of its Precision Plus spinal cord stimulator, has gained US premarket approval (PMA). The Clik Anchor uses a locking system to fix the leads – the wires through which painkilling impulses pass – more quickly and consistently. It locks into place on the lead with a turn of an Allen key and provides tactile and audible confirmation that the lead is secured. The firm will launch the Clik Anchor immediately. The Precision Plus is indicated for the management of chronic intractable pain of the trunk and/or limbs. The leads themselves were approved in the US last year (www.clinica.co.uk, 2 August 2010)
You may also be interested in...
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.